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Fungal infections after kidney transplantation are a major cause of morbidity and mortality, and Candida infection of the pancreas
is considered an infrequent but important agent in necrotizing pancreatitis. We report the case of a 43-year-old Caucasian patient
whounderwentsimultaneouspancreas-kidneytransplantationbecauseofdiabetestypeI,andchronicrenalfailurewithperitoneal
dialysis. The postoperative course was complicated by acute pancreatitis due to the thrombosis of the splenic artery of the graft, the
subsequent acute rupture of the external iliac artery caused by fungal arteritis (Candida glabrata), and peritonitis a few days later
causedbysigmoidperforationwithdetectionofCandidaglabratainfectionoftheresectedintestinaltract.Thepresentcaseremarks
that awareness and prevention of fungal infection are major issues in the transplant ﬁeld. Important information can be added
by systematic culture of conservation perfusates but, probably, the best way for early recognition of a critical level of infectious
risk remains the routine application of the colonization index screening. In cases of positive results, preemptive antifungal therapy
could be warranted.
1.Introduction
Infections remain a major challenge among transplant recip-
ients. In the early posttransplant phase the most common
[1]ar elocalorsyst emicsev er eCandidaspp.infections,either
endogenous or exogenous [2].
A risk factor analysis has shown that patients with severe
injuryofthepancreasaresigniﬁcantlymorepronetodevelop
a Candida infection [3]. We describe a disseminated fungal
infection as a complication of acute pancreatitis of the graft
after simultaneous pancreas-kidney transplantation (SPKT).
2.CaseReport
A 43-year-old Caucasian male suﬀering from type 1 diabetes
and chronic renal failure with peritoneal dialysis underwent
SPKT in December 2008. The donor was a 26-year-old male;
the cross-match was negative. The transplant procedure was
performed with no complications: the pancreas venous out-
ﬂow was systemic via an end-to-side anastomosis between
the portal vein of the graft and the recipient’s vena cava.
The inﬂow was restored through an end-to-side anastomosis
between the donor’s Y iliac graft and the recipient’s common
iliac axis. An enteric exocrine drainage was carried out on
a jejunal loop. The kidney was transplanted intraperitoneally
witharterialandvenousanastomosisontheleftexternaliliac
axis. The cold and warm ischemia times were 355 and 510
minutes, 45 and 35 minutes for the pancreas and the kidney,
respectively.
Antibiotic surgical prophylaxis with intravenous cefa-
zolin (2 grams single dose) was administered. Immuno-
suppressive therapy consisted of Basiliximab, Tacrolimus,
Steroids, and Mofetil Mycophenolic. Eight days after trans-
plantation the pancreas had to be removed because of the
development of acute pancreatitis due to the thrombosis
of the splenic artery of the graft. Empirical antimicrobial
therapy with Piperacillin-Tazobactam (2.2 grams X4/day
i.v) and Fluconazole (400mg/day i.v.) was administered.
On postoperative day 7 the patient underwent emergency
operation.Asuccessfulsutureoftherightexternaliliacartery2 Journal of Transplantation
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Figure 1: (a) 10x, Hematoxylin and eosin. Arterial wall with necrosis and inﬂammatory inﬁltrates; (b) 20x, Grocott. Fungal iphae in the
arterial wall.
(a) (b)
Figure 2: (a) 10x, Hematoxylin and eosin. Phlogosis of the intestinal sierosa; (b) 20x, Grocott. Fungal iphae in the arterial wall.
was performed because of an acute rupture. Histological
examination of the artery evidenced fungal arteritis by
Candida Glabrata (C. Glabrata) with extended necrosis
(Figures1(a)and1(b)),andcultureyieldedC.Glabrata,with
dose-dependent ﬂuconazole and itraconazole sensitivity (S-
DD).
Antimycotic therapy with Caspofungin (50mg/day after
a loading dose of 70mg) was immediately started. Again,
eight days later, the patient developed peritonitis and under-
went another emergency operation; a Hartmann procedure
was performed on the intraoperative ﬁnding of single
perforation of the sigmoid colon. Histological examination
of the intestinal tract evidenced the presence of fungal spores
and C. Glabrata grew from culture of surgical specimens
(Figures 2(a) and 2(b)), although the patient had already
started antimycotic therapy with Capsofungin (eﬀective
on C. Glabrata). The antimtycotic therapy, started 8 days
before, was apparently insuﬃcient to eradicate C. Glabrata
completely. On histological examination the surgical spec-
imen revealed, besides fungal iphae, ischemic type lesions,
probably responsible for perforation.
The postoperative course was regular, the patient was
switched from Caspofungin (total therapy 25 days) to Flu-
conazole (400gm/die administered orally), and was dis-
charged from hospital in good general conditions. One year
follow-up has been regular.
3. Discussion
Candida is more likely to cause infection in patient having
surgery for acute pancreatitis than in those with either gas-
trointestinal perforations or other surgical conditions [4–6].
In the transplantation ﬁeld, arterial infection associated with
Candida is an emerging problem. Some authors suggest that
the infection is transmitted from the donor, with a potential
source of infection represented by the contaminated graft,
whereas the variability of the infectious risk is related to
the duration and complexity of the harvesting and storage
process [7]. However, in our case no risk factors or positive
fungal cultures were reported from the donor; no signs
or symptoms suggestive of systemic fungal infection were
present in our case before transplant. Blood and urinary
cultures were always negative. The patient had a major risk
factor for Candida infection, represented by a history of
peritoneal dialysis [8], but no episodes of peritonitis or other
infections had been reported before transplant. Moreover
during the post transplant phase, no blood cultures were
positive for Candida spp.
Therefore, while the colonic localization of Candida spp
might be related to an endogenous source, the development
of the arteritis is more diﬃcult to explain without any
episode of candidemia and graft contamination remains the
more reasonable pathogenetic mechanism of infection [9].Journal of Transplantation 3
From a therapeutic point of view, it is worth remarking
that invasive Candidiasis developed despite Fluconazole
therapy;althoughtheisolationofanS-DDC.Glabratastrain
well explains the Fluconazole failure [10].
In literature, the incidence of gastrointestinal complica-
tions in renal transplantation is relatively high, about 20%.
Many predisposing factors have been suggested as steroids
use, uremia and wound-healing capacity, chronic constipa-
tion, atherosclerotic change of the colon vascularization, and
soforth,althoughthemaincausesreportedarecomplication
of a preexisting diverticular disease and intestinal ischemia
[11, 12].
In conclusion, this case points out that awareness and
prevention of fungal infections are major issues in the tra-
nsplant ﬁeld. The best way for the early recognition of infec-
tious risk remains the routine application of the colonization
index screening [13], followed by preemptive antifungal
therapy in case of positive results.
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